Pauwels Eric (CIK 1323212) reported 60 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-12). Recent activity: Sell PTCT (3,711 shares), Buy PTCT (17,566 shares), Sell PTCT (17,566 shares), Sell PTCT (3,019 shares), Sell PTCT (2,561 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 3,711 | $278,325 |
| 2026-06-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Buy | 17,566 | $316,364 |
| 2026-06-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 17,566 | $1.3M |
| 2026-02-20 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 3,019 | $209,398 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 2,561 | $195,712 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 587 | $45,187 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,454 | $111,158 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,722 | $133,300 |
| 2026-01-12 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,024 | $80,589 |
| 2026-01-08 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,789 | $137,664 |
| 2026-01-08 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,352 | $104,753 |
| 2026-01-06 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Buy | 20,000 | $0 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Buy | 138 | $9,176 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 37 | $2,799 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 42 | $3,245 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 59 | $4,603 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Buy | 565 | $10,176 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 193 | $14,562 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 313 | $24,329 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 59 | $4,627 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Buy | 19,805 | $1.3M |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 1,500 | $113,655 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 4,537 | $346,309 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 10,548 | $817,997 |
| 2025-12-23 | PTC THERAPEUTICS, INC. (PTCT) | CHIEF BUSINESS OFFICER | Sell | 3,220 | $252,223 |
Source: SEC Form 4 filings · as of 2026-06-12